圣诺菲首席执行官保罗·哈德森在财富全球论坛上警告称，一些公司夸大了AI在医疗保健中的应用。他认为，企业需要更谨慎地描述其AI能力，并建立相应的伦理审查机制。哈德森将AI在医疗保健中的应用分为两类：专家AI和便携AI。专家AI可用于加速药物研发，而便携AI则可帮助人们做出更好的医疗保健决策。他强调，AI在医疗保健领域拥有巨大潜力，但企业需要管理其风险，并保持透明度，避免过度炒作。

🤔 **AI在医疗保健中的应用迅速发展，涵盖了医疗资源获取、药物研发和缓解医生倦怠等领域。** 但一些公司领导者在描述其AI能力时存在夸大现象，需要更加谨慎地评估AI的实际应用和潜在风险。

👨‍⚕️ **圣诺菲首席执行官保罗·哈德森提出，AI在医疗保健中的应用可以分为两类：专家AI和便携AI。** 专家AI主要应用于结构生物学和分子识别，加速药物研发；而便携AI则侧重于日常生活的应用，例如帮助人们做出更好的医疗保健决策。

📊 **圣诺菲每天有18000名客户使用AI进行“便携式”健康管理。** 这体现了AI在提升医疗保健可及性和个性化方面所具备的潜力，同时也展现了AI在规模化应用方面的前景。

⚠️ **哈德森强调，AI在医疗保健领域拥有巨大潜力，但同时需要管理其风险。** 企业需要保持透明度，将AI的实际应用与未来预期进行区分，避免过度炒作，并建立相应的伦理审查机制。

💡 **哈德森呼吁企业在使用AI时，需要制定游戏规则，并建立伦理审查机制，确保AI的应用符合道德规范和社会利益。** 这强调了AI应用中伦理和责任的重要性，需要企业在追求创新和发展的同时，注重AI应用的安全性、可靠性和公平性。

AI’s role in health care is rapidly evolving to solve some of the largest problems, including access, drug discovery, and physician burnout. However, Paul Hudson, CEO of Sanofi, one of the world’s leading biopharmaceutical companies, says executives may need to rein themselves in when it comes down to how they describe their AI capabilities.At Fortune’s Global Forum in New York City Monday, Hudson warned that executives have often exaggerated how AI is used by their companies. “There is a lot of AI washing and CEOs talking about AI projects,” he said, alluding to the tactic of overselling AI’s potential without thinking through how to mitigate its risks.“You have to have rules of the game,” Hudson said, touting Sanofi’s AI ethical review board, which projects are required to go through. “We need to be a bit more sophisticated in how we calibrate the AI.”Sanofi, which ranks 297th on the Fortune Global 500, recently announced it would sell a 50% stake of its consumer healthcare business Opella in an effort to focus primarily on innovation within biopharma.For Hudson, AI’s potential in health care falls into two buckets: “expert AI” and “snackable AI.”Expert AI refers to how the technology can target structural biology and identify molecules to accelerate drug discovery for a host of diseases.Snackable AI, in turn, is how the technology can infiltrate the everyday lives of customers in practical ways. Similar to how Waze—a software tool that gives realtime driving directions—can nudge people on whether it’s better to turn right or left, Hudson says snackable AI can do the same when it comes to people’s healthcare decisions. Hudson estimates 18,000 Sanofi customers use AI in a “snackable format” every day. At scale, it will help people “make better decisions [and] democratize data to unleash the resources of the company. That’s actually more fun than people realize.”In the long term, Hudson sees AI as a way to break down the barrier to access health tools and customize them depending on the data—but urges executives to be transparent and distinguish reality from futuristic speculation.“AI is a huge opportunity and we can’t be deniers, but we do have to manage the risks,” he said. A newsletter for the boldest, brightest leaders: CEO Daily is your weekday morning dossier on the news, trends, and chatter business leaders need to know. Sign up here.